| WAZ median (IQR) |
-1.07 (-1.92;-0.09) n = 168 |
-1.06 (-1.78; -0.07) n = 135 |
-1.25 (-2.44;-0.44) n = 33 |
0.28 |
| HAZ median (IQR) |
1.31 (-1.94; -0.49) N = 168 |
-1.31 (-2.11; -0.48) n = 134 |
-1.35 (-1.81; -0.50) |
099 |
| WHZ median (IQR) |
-0.16 (-1.05; -0.52) n = 166 |
-0.17 (-1.03;0.50) n = 133 |
-0.11 (-1.34;0.66) n = 33 |
0.67 |
| CD4+ % |
30.3 (24.1; 36.5) |
31 (25.3; 37.9) n = 119 |
27.4 (20.75; 32.02) n = 34 |
0.0173 |
| CD4+ cells/mm3
|
1598 (1195; 2201) |
1582 (1168; 2194) |
1679 (1366; 2216) |
0.49 |
| Plasma HIV-RNA Log10copies/mm3
|
1.96 (1.7; 3.1) |
1.94 (1.7; 3.09) |
2.3 (1.7: 3.67) |
0.47 |
| Plasma HIV-RNA <400 copies/mm3
|
91(53.5%) |
101 (64.3%) |
28 (68.3%) |
0.39 |
| Change between baseline and study end in those ≥20 weeks on study |
| WAZ |
0.60 (-0.27;1.65) n = 169 |
0.42(-0.3;1.76) n = 124 |
0.74(0.17;1.52) |
0.27 |
| HAZ |
0.25 (-0.17;0.83) n = 159 |
0.24(-0.22;0.7) n = 128 |
0.48(0.03;1.31) n = 31 |
0.087 |
| WHZ |
0.42 (-0.57;2.07) n = 153 |
0.49(-0.56;2.06) n = 122 |
0.35(-1.07;2.11) n = 31 |
0.69 |
| CD4+ % |
8.5 n = 150 |
8 (3.13;14) n = 116 |
9.25 (4.7; 13.63) n = 34 |
0.90 |
| CD4+ cells/mm3
|
498 (16.3; 1071) |
372 (-17,5; 971) |
868 (320; 1352) |
0.015 |
| Plasma HIV-RNA Log10copies/mm3
|
3.59 (4.22; 2.4) |
3.49 (-4.14; -2.38) |
4.01 (-4.51; -2.75) |
0.052 |